Harris Matthew Scott

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return 31% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Harris Matthew Scott's trades of Altimmune Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
300.47
Quantity 51,167 +41.1%
Value US$2,014,919
Transaction date
Planned sale
Price
85.54
Quantity 97,263 -17.4%
Value US$4,781,880
Transaction date
Planned sale
Price
488.48
Quantity 8,617 +28.5%
Value US$2,282,424
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-23 2023-03-23
B Purchase
51,167 +41.1%
300.47
US$2,014,919 		51,167 +41.1% 300.47 US$2,014,919
2022-03-02 2022-02-28
PlS Planned sale
97,263 -17.4%
85.54
US$4,781,880 		97,263 -17.4% 85.54 US$4,781,880
2020-11-13 2020-11-12
PlS Planned sale
8,617 +28.5%
488.48
US$2,282,424 		8,617 +28.5% 488.48 US$2,282,424